PreOmics GmbH

PreOmics is as a spin-off company from the proteomics research group of pioneer Matthias Mann at the Max-Planck Institute of Biochemistry. We at PreOmics develop and provide innovative technologies for mass spectrometry-based proteomics to make your research simply better. Our mission is to provide you with the best possible solutions and highest quality to achieve your results faster, easier and with better robustness than ever before.
We at PreOmics believe that our technology will allow entirely new insights in disease mechanisms and revolutionizes personalized medicine as well as companion diagnostics for a better healthcare.
  • Mitarbeiterzahl

    4
  • Gegründet

    2016
  • Aktualisiert am

    20.02.2017